Sort
15,842 grants matching “pancreatic cancer”
Chromatin and immune regulation of tumor growth and progression
$49,194Emily Lorin Ashkin · Stanford University · F99 · FY2023 · CA
Fibroblasts in the establishment of the liver pre-metastatic niche
$49,194Michelle Kayoko Ozaki · Oregon Health & Science University · F99 · FY2023 · CA
Development and Testing of a Novel Biospecific using modified Gemcitibine to target and treat Pancreatic Cancer
$49,136Edward Kwasi Agyare · Florida Agricultural And Mechanical Univ · U54 · FY2023 · CA
Pilot Project 5 - Pancreatic Treatment
$49,135Edward Kwasi Agyare · Florida Agricultural And Mechanical Univ · U54 · FY2025 · CA
Developmental Research Program
$49,118Martin Ernesto Fernandez-Zapico · Mayo Clinic Rochester · P50 · FY2015 · CA
Chimeric Antigen Receptor Modified T Cell Therapy for Pancreatic Cancer
$49,058Somala Mohammed · Baylor College Of Medicine · F32 · FY2014 · CA
Mechanisms of Escape from TGFβ Tumor Suppression in the Pancreas
$49,044Yun-Han Huang · Weill Medical Coll Of Cornell Univ · F30 · FY2017 · CA
Long Non-Coding RNA-mediated Differential Regulation of Notch Pathway Targets in Early T-cell Development
$49,044Abhik Banerjee · California Institute Of Technology · F30 · FY2017 · HL
Role of Nix in pancreatic ductal adenocarcinoma
$49,044Brinda Alagesan · State University New York Stony Brook · F30 · FY2017 · CA
Tumor expressed B7x accelerates disease and is a novel target for immunotherapy
$49,044Kim C Ohaegbulam · Albert Einstein College Of Medicine, Inc · F31 · FY2017 · CA
Validation of WEE1 kinase as a clinical target in KRAS-mutant pancreatic cancer
$48,989John Nathaniel Diehl · Univ Of North Carolina Chapel Hill · F30 · FY2022 · CA
HORMONES: BIOCHEMISTRY AND MOLECULAR BIOLOGY
$48,976Max Elliot Gottesman · Columbia University Health Sciences · T32 · FY2013 · DK
Engineering CD4+ T cells to develop a novel immunotherapy for pancreatic cancer
$48,974Delaney Kate Geitgey · Emory University · F31 · FY2024 · CA
Understanding Kras Mutation Heterogeneity in PDAC
$48,974Whitney Juliet Sisso · Weill Medical Coll Of Cornell Univ · F31 · FY2024 · CA
Immune Regulation of Dormancy at the Metastatic Site
$48,974Xiao Han · State University New York Stony Brook · F99 · FY2024 · CA
Mechanisms of gene expression regulation in pancreatic cancer
$48,974David R Pease · Mayo Clinic Rochester · F99 · FY2024 · CA
Defining Novel Redox Stress Mechanisms to Inhibit KRAS-driven Pancreatic Ductal Adenocarcinoma
$48,974Beatriz Mateo-Victoriano · University Of Miami School Of Medicine · F31 · FY2024 · CA
Fibroblasts in the establishment of the liver pre-metastatic niche
$48,974Michelle Kayoko Ozaki · Oregon Health & Science University · F99 · FY2024 · CA
Understanding the divergent functions of mutant p53
$48,974Margaret Kennedy · Sloan-Kettering Inst Can Research · F31 · FY2024 · CA
Role of PDK1 in pancreatic cancer cell fitness under tumor nutrient stress
$48,974Colin Sheehan · University Of Chicago · F31 · FY2024 · CA
Defining novel functions of ATF4 in early stages of pancreatic cancer tumorigenesis
$48,974Leah Marie Ziolkowski · University Of Chicago · F31 · FY2024 · CA
Targeting of Krüppel-like Factor 5 (KLF5) in Pancreatic Ductal Adenocarcinoma
$48,974Patrick Cunniff · Cold Spring Harbor Laboratory · F31 · FY2024 · CA
Phosphorylated Form of Activated IKKbeta and Pancreatic Cancer
$48,937Amarnath Natarajan · University Of Nebraska Medical Center · R21 · FY2015 · CA
Center for digestive and liver diseases
$48,844Anil K Rustgi · University Of Pennsylvania · P30 · FY2009 · DK
Gastrointestinal Cancer Research Program (GI) (Project-005)
$48,839Jordan D Berlin · Vanderbilt University Medical Center · P30 · FY2015 · CA